Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 1;7(1):131-132.
doi: 10.1001/jamaoncol.2020.5748.

Association of the COVID-19 Outbreak With Patient Willingness to Enroll in Cancer Clinical Trials

Mark E Fleury  1 , Amy M Farner  1   2 , Joseph M Unger  3
Affiliations

Association of the COVID-19 Outbreak With Patient Willingness to Enroll in Cancer Clinical Trials

Mark E Fleury et al. JAMA Oncol. .

Abstract

This survey study examines the attitudes of a large group of cancer survivors toward trial participation during the coronavirus disease 2019 outbreak.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure 1.
Figure 1.. Change in Likelihood to Participate in Cancer Clinical Trials in Light of COVID-19 Pandemic
Responses indicating no difference are not shown. There were no differences in the rates of those replying that they were more likely to participate vs less likely to participate by levels of age, gender, household income, or care setting. Percentages are based on respondents with known data. Subgroup examinations by race were not included owing to the small sample of non-White patients, including Black (n = 33), Asian/Pacific Islander (n = 19), and Native American (n = 14). Unknown patient data included age (n = 13), race (n = 13), household income (n = 9), gender (n = 9), and care setting (n = 5). One participant indicated that they were transgender. For 147 participants, household income was recorded as prefer not to answer. The majority of participants (69.1%) had 1 of the 4 most common cancers (breast [45.9%], colorectal [7.4%], lung [7.7%], or prostate [8.1%]).
Figure 2.
Figure 2.. Reasons for Reduced Likelihood of Participating in Clinical Trials
See this image and copyright information in PMC

Comment in

References

    1. Unger JM, Blanke CD, LeBlanc M, Hershman DL. Association of the coronavirus disease 2019 (COVID-19) outbreak with enrollment in cancer clinical trials. JAMA Netw Open. 2020;3(6):e2010651. doi: 10.1001/jamanetworkopen.2020.10651 - DOI - PMC - PubMed
    1. Richards M, Anderson M, Carter P, Ebert BL, Mossialos E. The impact of the COVID-19 pandemic on cancer care. Nat Cancer. 2020;1:1-3. doi: 10.1038/s43018-020-0074-y - DOI - PMC - PubMed
    1. American Cancer Society Cancer Action Network . COVID survey questions. Accessed October 8, 2020. https://www.fightcancer.org/sites/default/files/docs/resources/CT_COVID_...
    1. National Cancer Institute . Coronavirus guidance. Updated April 1, 2020. Accessed April 9, 2020. https://ctep.cancer.gov/investigatorResources/corona_virus_guidance.htm
    1. US Food and Drug Administration . FDA guidance on conduct of clinical trials of medical products during COVID-19 public health emergency. Updated September 21, 2020. Accessed October 8, 2020. https://www.fda.gov/regulatory-information/search-fda-guidance-documents...

Publication types